These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 28581266)
1. Characteristics of Drug Resistant Tuberculosis in Sanatoria of North Korea. Jung J; Jegal Y; Ki M; Shin YJ; Kim CT; Shim TS; Sung N J Korean Med Sci; 2017 Jul; 32(7):1105-1110. PubMed ID: 28581266 [TBL] [Abstract][Full Text] [Related]
2. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center. Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663 [TBL] [Abstract][Full Text] [Related]
3. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design. Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290 [TBL] [Abstract][Full Text] [Related]
4. Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019. Lee T; Lee SJ; Jeon D; Lee HY; Kim HJ; Kang BH; Mok J J Korean Med Sci; 2021 Jul; 36(26):e174. PubMed ID: 34227261 [TBL] [Abstract][Full Text] [Related]
5. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns. Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
7. Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible? Seung KJ; Franke M; Linton SW PLoS Med; 2016 Aug; 13(8):e1002062. PubMed ID: 27483430 [TBL] [Abstract][Full Text] [Related]
8. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
9. High degree of fluoroquinolone resistance among pulmonary tuberculosis patients in New Delhi, India. Sharma R; Sharma SK; Singh BK; Mittal A; Kumar P Indian J Med Res; 2019 Jan; 149(1):62-66. PubMed ID: 31115377 [TBL] [Abstract][Full Text] [Related]
10. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis. Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491 [TBL] [Abstract][Full Text] [Related]
12. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997]. Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966 [TBL] [Abstract][Full Text] [Related]
13. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India. Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350 [TBL] [Abstract][Full Text] [Related]
14. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823 [TBL] [Abstract][Full Text] [Related]
15. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China]. Shen X; Li J; Gao Q; Xu B; Mei J Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519 [TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015. Lee M; Han J; Kim YR; Kwak N; Kim JH; Park O; Shin S; Moon HS; Kim HJ; Jang MJ; Yim JJ Int J Tuberc Lung Dis; 2019 Jul; 23(7):850-857. PubMed ID: 31439118 [No Abstract] [Full Text] [Related]
17. Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea? Lee S; Lee SH; Mok JH; Lee SJ; Kim KH; Lee JE; Lee SG; Chung JS; Kwak IS Yonsei Med J; 2016 Nov; 57(6):1508-10. PubMed ID: 27593882 [TBL] [Abstract][Full Text] [Related]
19. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. Choi JC; Lim SY; Suh GY; Chung MP; Kim H; Kwon OJ; Lee NY; Park YK; Bai GH; Koh WJ J Korean Med Sci; 2007 Aug; 22(4):677-81. PubMed ID: 17728509 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014. Diarra B; Goita D; Tounkara S; Sanogo M; Baya B; Togo AC; Maiga M; Sarro YS; Kone A; Kone B; M'Baye O; Coulibaly N; Kassambara H; Cisse A; Belson M; Polis MA; Otu J; Gehre F; Antonio M; Dao S; Siddiqui S; Murphy RL; de Jong BC; Diallo S BMC Infect Dis; 2016 Nov; 16(1):714. PubMed ID: 27894266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]